NONOFNovo-Nordisk A/S

About Novo-Nordisk A/S (NONOF)

Novo-Nordisk A/S (NONOF) is a Drug Manufacturers - General company headquartered in New York, NY, United States whose shares trade over-the-counter on the Pink tier.

Novo-Nordisk is the parent company of a group engaged in the development, production and marketing of pharmaceuticals, biological solutions to industrial problems; vitamins, dietary supplements and digestive aids. Co. operates on a worldwide basis in two business segments: Diabetes care: discovery, development, manufacturing and marketing of products within the areas of insulin and delivery systems and oral antidiabetic products (OAD). Biopharmaceuticals: discovery, development, manufacturing and marketing of products within the therapy areas haemostasis management (NovoSeven(R) RT), growth hormone therapy, hormone replacement therapy and other products.

NONOF key facts

Ticker symbol

NONOF

Market tier

Pink

Sector

Healthcare

Industry

Drug Manufacturers - General

Headquarters

New York, NY, United States

Country of incorporation

DK

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

12/31

Novo-Nordisk A/S leadership

• Lars A. Sorensen — President, CEO
• Kaare Schultz — COO
• Jesper Brandgaard — CFO

Explore more: Drug Manufacturers - General stocks · Healthcare sector · Pink stocks · OTC stocks starting with N